BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, December 15, 2024
See today's BioWorld
Home
» Other news to note for Jan. 19, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Jan. 19, 2021
Jan. 19, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aavnergene, Advaxis, Aptinyx, Boehringer Ingelheim, Brickbio, Capricor, Cocrystal, Conserv, Cure Genetics, Elsalys, Etana, Everest, Faron, Gritstone, Hanmi, Immunitybio, Innovent, Intravacc, Invixa, Janssen, Lipigon, Merck & Co., Minerva, Miragen, Neucyte, Neurogene, Neurophth, Novadiscovery, Oncosec, Orchard, OS Therapies, Oxford, Propanc, Provention, Royalty, Secarna, Spero, Syntekabio, Tenax, Tennor, Twist, Vigeneron, Viridian.
BioWorld
Briefs
Other news to note
Coronavirus